Market Overview:
The global herpes marker testing market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing prevalence of herpes infections, rising demand for early diagnosis and treatment, and technological advancements in diagnostic tests. Based on type, the global herpes marker testing market is segmented into HSV-1, HSV-2, and HSV-1/HSV-2. The HSV-1 segment is expected to account for the largest share of the global herpes marker testing market in 2018. This can be attributed to the high prevalence of this virus among adults worldwide. Based on application, the global herpes marker testing market is segmented into research and clinic settings.
Product Definition:
Herpes Marker Testing is the process of testing a person for the presence of herpes simplex virus antibodies. These antibodies are produced by the body in response to a viral infection. Herpes Marker Testing can be used to diagnose herpes infections, to determine if a person has been recently infected with herpes, or to monitor the effectiveness of treatment.
HSV-1:
HSV-1 is also known as genital herpes, generally caused by the HSV-1 virus. It is commonly found in children and most often causes cold sores around the mouth. The virus can also cause chickenpox, shingles, and zoster (shingles). Genital herpes simplex can be primary or secondary depending on the time of infection. Primary infection usually occurs when a person has no prior exposure to oral or genital sex.
HSV-2:
HSV-2 is also known as genital herpes. It is a viral infection of the skin and mucous membranes that occur in the oropharynx, anogenital area, and buttocks. The virus can be transmitted through oral-genital contact, most notably during vaginal or anal sex. HSV-2 can also be acquired from contaminated objects like towels, bed sheets or even from one’s own body fluids (such as urine or saliva).
Application Insights:
Based on the application, the global herpes marker testing market is segmented into research, and clinic. The research segment dominated the overall market in terms of revenue in 2017. This is due to a rise in prevalence of diseases such as HSV-1 and HSV-2 that use these tests for diagnosis. According to WHO, it was estimated that around 1% to 2% of population across the globe are carriers of HSV infection; however, only 0.5% to 1% people get infected with Herpes Simplex Virus (HSV) each year. Thus rising prevalence leads towards growth in demand for diagnostic solutions which include viral load testing which is majorly used for diagnosing HIV infections among adults along with other sexually transmitted diseases (STD).
The Clinic segment will witness significant growth over forecast period owing to an increase number of new clinics opening up especially throughout North America.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of players, high adoption rate for new diagnostic technologies and increasing prevalence of genital herpes are some factors attributing to its largest share. Moreover, government initiatives to create awareness about the disease and launch marketing campaigns are also responsible for its large share. For instance, in February 2018, CDC launched an awareness advertising campaign on TV & radio stations across the U.S.
Asia Pacific is expected to grow at a lucrative CAGR over the forecast period owing to continuous research activities related to development of novel tests for detection of HSV infection coupled with rising incidence rates due herpetic diseases in this region especially China.
Growth Factors:
- Increasing incidence of herpes infections: The global herpes infection rate is on the rise, owing to various factors such as changing sexual behavior, increasing number of people with compromised immune systems, and rising awareness about the disease. This is expected to drive demand for herpes marker testing products and services in the coming years.
- Growing demand for early diagnosis and treatment: Herpes infections can be effectively treated if diagnosed in early stages. There is a growing demand for accurate and rapid diagnostic tests that can help identify herpes infections at an early stage, so that appropriate treatment can be initiated without delay. This is expected to boost growth of the global herpes marker testing market in the coming years.
- Technological advancements: The development of new technologies has led to introduction of novel diagnostic tests for detection of HSV-1 and HSV-2 antibodies in blood samples. These technological advancements are likely to fuel growth of the global herpes marker testing market in future years..
Scope Of The Report
Report Attributes
Report Details
Report Title
Herpes Marker Testing Market Research Report
By Type
HSV-1, HSV-2, HSV-1/ HSV-2
By Application
Research, Clinic
By Companies
Abbott Laboratories, Abcam Plc, BioMérieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc, Teco Diagnostics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
132
Number of Tables & Figures
93
Customization Available
Yes, the report can be customized as per your need.
Global Herpes Marker Testing Market Report Segments:
The global Herpes Marker Testing market is segmented on the basis of:
Types
HSV-1, HSV-2, HSV-1/ HSV-2
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Research, Clinic
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- Abcam Plc
- BioMérieux SA
- Thermo Fisher Scientific, Inc.
- F. Hoffmann-La Roche Ltd.
- DiaSorin S.p.A.
- Quidel Corporation
- Luminex Corporation
- Merck KGaA
- Qiagen N.V.
- Norgen Biotek Corp.
- Hologic Inc.
- Bio Rad Laboratories Inc.
- Meridian Bioscience Inc
- Teco Diagnostics
Highlights of The Herpes Marker Testing Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- HSV-1
- HSV-2
- HSV-1/ HSV-2
- By Application:
- Research
- Clinic
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Herpes Marker Testing Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Herpes marker testing is a blood test that can help to identify if someone has herpes. This test can be used to determine whether someone has had an outbreak of herpes, or if they are likely to develop the virus in the future.
Some of the key players operating in the herpes marker testing market are Abbott Laboratories, Abcam Plc, BioM©rieux SA, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., DiaSorin S.p.A., Quidel Corporation, Luminex Corporation, Merck KGaA, Qiagen N.V., Norgen Biotek Corp., Hologic Inc., Bio Rad Laboratories Inc., Meridian Bioscience Inc, Teco Diagnostics.
The herpes marker testing market is expected to grow at a compound annual growth rate of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Herpes Marker Testing Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Herpes Marker Testing Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Herpes Marker Testing Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Herpes Marker Testing Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Herpes Marker Testing Market Size & Forecast, 2020-2028
4.5.1 Herpes Marker Testing Market Size and Y-o-Y Growth
4.5.2 Herpes Marker Testing Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 HSV-1
5.2.2 HSV-2
5.2.3 HSV-1/ HSV-2
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Research
6.2.2 Clinic
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Herpes Marker Testing Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Herpes Marker Testing Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 HSV-1
9.6.2 HSV-2
9.6.3 HSV-1/ HSV-2
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Research
9.10.2 Clinic
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 HSV-1
10.6.2 HSV-2
10.6.3 HSV-1/ HSV-2
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Research
10.10.2 Clinic
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 HSV-1
11.6.2 HSV-2
11.6.3 HSV-1/ HSV-2
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Research
11.10.2 Clinic
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 HSV-1
12.6.2 HSV-2
12.6.3 HSV-1/ HSV-2
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Research
12.10.2 Clinic
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 HSV-1
13.6.2 HSV-2
13.6.3 HSV-1/ HSV-2
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Research
13.10.2 Clinic
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Herpes Marker Testing Market: Competitive Dashboard
14.2 Global Herpes Marker Testing Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Laboratories
14.3.2 Abcam Plc
14.3.3 BioMérieux SA
14.3.4 Thermo Fisher Scientific, Inc.
14.3.5 F. Hoffmann-La Roche Ltd.
14.3.6 DiaSorin S.p.A.
14.3.7 Quidel Corporation
14.3.8 Luminex Corporation
14.3.9 Merck KGaA
14.3.10 Qiagen N.V.
14.3.11 Norgen Biotek Corp.
14.3.12 Hologic Inc.
14.3.13 Bio Rad Laboratories Inc.
14.3.14 Meridian Bioscience Inc
14.3.15 Teco Diagnostics
